4th Quarter - Report

PHARMAVITE LLC for PHARMAVITE LLC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$50,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Mar 12, 2010 $50,000 Replaced
4th Quarter - Amendment Jul 23, 2010 $80,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Food Industry (safety, labeling, etc.) FOO

Food safety bills in the Senate and the House (specific bill S. 510) and their potential impact on the dietary supplement industry. Support for increase for FDA funding to enforce the Dietary Supplement Health and Education act. Support for Section 327 of the Senate version of the Health Care Reform bill for a Wellness Demonstration Project

LobbyistCovered position, as disclosed
CAROLYN J SABATINI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 510 (111th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
OTSUKA PHARMACEUTICAL CO. LTD. Japan Japan 100.0% —
OTSUKA HOLDINGS CO. LTD Japan Japan 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.